Pathological role of osteoclast costimulation in arthritis-induced bone loss

S Ochi, M Shinohara, K Sato… - Proceedings of the …, 2007 - National Acad Sciences
S Ochi, M Shinohara, K Sato, HJ Gober, T Koga, T Kodama, T Takai, N Miyasaka…
Proceedings of the National Academy of Sciences, 2007National Acad Sciences
Abnormal T cell immune responses induce aberrant expression of inflammatory cytokines
such as TNF-α, leading to osteoclastmediated bone erosion and osteoporosis in
autoimmune arthritis. However, the mechanism underlying enhanced osteoclastogenesis in
arthritis is not completely understood. Here we show that TNF-α contributes to inflammatory
bone loss by enhancing the osteoclastogenic potential of osteoclast precursor cells through
inducing paired Ig-like receptor-A (PIR-A), a costimulatory receptor for receptor activator of …
Abnormal T cell immune responses induce aberrant expression of inflammatory cytokines such as TNF-α, leading to osteoclastmediated bone erosion and osteoporosis in autoimmune arthritis. However, the mechanism underlying enhanced osteoclastogenesis in arthritis is not completely understood. Here we show that TNF-α contributes to inflammatory bone loss by enhancing the osteoclastogenic potential of osteoclast precursor cells through inducing paired Ig-like receptor-A (PIR-A), a costimulatory receptor for receptor activator of NF-κB (RANK). In fact, bone erosion and osteoporosis, but not inflammation, caused by aberrant TNF-α expression were ameliorated in mice deficient in Fc receptor common γ subunit or β2-microglobulin, in which the expression of PIR-As and PIR-A ligands is impaired, respectively. These results establish the pathological role of costimulatory receptors for RANK in bone loss in arthritis and may provide a molecular basis for the future therapy of inflammatory diseases.
National Acad Sciences